Zeria Pharmaceutical Co., Ltd. (TYO:4559)

Market Cap	91.86B
Revenue (ttm)	87.31B
Net Income (ttm)	9.94B
Shares Out	44.08M
EPS (ttm)	225.41
PE Ratio	9.25
Forward PE	9.28
Dividend	48.00 (2.32%)
Ex-Dividend Date	Sep 29, 2025

Volume	31,400
Average Volume	65,190
Open	2,070.00
Previous Close	2,071.00
Day's Range	2,064.00 - 2,084.00
52-Week Range	1,970.00 - 2,505.00
Beta	0.06
RSI	55.20
Earnings Date	Aug 5, 2025

About Zeria Pharmaceutical

Zeria Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural and industrial chemicals, and reagents in Japan and internationally. The company operates through Ethical Pharmaceuticals Business and Consumer Healthcare Business segments. It also provides cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, health equipment, hygiene facilities and e...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1955
• Employees: 1,746
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4559

Financial Performance

In 2024, Zeria Pharmaceutical's revenue was 87.31 billion, an increase of 15.30% compared to the previous year's 75.73 billion. Earnings were 9.94 billion, an increase of 28.52%.